Histone Deacetylase 1 in Patients With Alopecia Areata and Acne Vulgaris: An Epigenetic Alteration

    Heba A. Abdelkader, Iman M. Amin, Laila Ahmed Rashed, Maha Samir, Marwa Ezzat
    TLDR Higher HDAC1 levels in alopecia areata suggest HDAC inhibitors might help treat it and acne.
    This study investigated the deregulation of histone deacetylase 1 (HDAC1) in patients with alopecia areata (AA) and acne vulgaris. Conducted as a case-control study with 76 participants, including 25 with patchy AA, 26 with acne vulgaris, and 25 healthy controls, the research measured HDAC1 levels using ELISA. Results showed a significant difference in serum HDAC1 levels among the groups, with the highest levels observed in the AA group. The findings suggested that HDAC1 deregulation might offer a potential therapeutic target for HDAC inhibitors in treating these conditions.
    Discuss this study in the Community →

    Research cited in this study

    6 / 6 results

    Related Community Posts Join

    2 / 2 results

    Similar Research

    5 / 1000+ results